These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37096837)

  • 1. Optimising the current model of care for knee osteoarthritis with the implementation of guideline recommended non-surgical treatments: a model-based health economic evaluation.
    Vetsch T; Taeymans J; Lutz N
    Swiss Med Wkly; 2023 Apr; 153():40059. PubMed ID: 37096837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifetime Cost-Effectiveness of Structured Education and Exercise Therapy for Knee Osteoarthritis in Australia.
    Docking S; Ademi Z; Barton C; Wallis JA; Harris IA; de Steiger R; Buchbinder R; Brusco N; Young K; Pazzinatto MF; Harries D; Vertullo CJ; Ackerman IN
    JAMA Netw Open; 2024 Oct; 7(10):e2436715. PubMed ID: 39352701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of total knee replacement in addition to non-surgical treatment: a 2-year outcome from a randomised trial in secondary care in Denmark.
    Skou ST; Roos E; Laursen M; Arendt-Nielsen L; Rasmussen S; Simonsen O; Ibsen R; Larsen AT; Kjellberg J
    BMJ Open; 2020 Jan; 10(1):e033495. PubMed ID: 31948990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Value of Total Knee Replacement in Patients With Knee Osteoarthritis and a Body Mass Index of 40 kg/m
    Chen AT; Bronsther CI; Stanley EE; Paltiel AD; Sullivan JK; Collins JE; Neogi T; Katz JN; Losina E
    Ann Intern Med; 2021 Jun; 174(6):747-757. PubMed ID: 33750190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Diet and Exercise for Overweight and Obese Patients With Knee Osteoarthritis.
    Losina E; Smith KC; Paltiel AD; Collins JE; Suter LG; Hunter DJ; Katz JN; Messier SP
    Arthritis Care Res (Hoboken); 2019 Jul; 71(7):855-864. PubMed ID: 30055077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland.
    Bhadhuri A; Dröschel D; Guldimann M; Jetschgo C; Banhazi J; Schwenkglenks M; Sutherland CS
    BMC Health Serv Res; 2022 Jun; 22(1):837. PubMed ID: 35765055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of access to musculoskeletal care: the case of waiting for total knee arthroplasty.
    Mather RC; Hug KT; Orlando LA; Watters TS; Koenig L; Nunley RM; Bolognesi MP
    BMC Musculoskelet Disord; 2014 Jan; 15():22. PubMed ID: 24438051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is It Worth Delaying Total Knee Replacement as Late as Possible? A Cost-Effectiveness Analysis Using a Markov Model in the Indian Setting.
    George J; Gautam D; Devasenapathy N; Malhotra R
    Value Health Reg Issues; 2021 May; 24():173-180. PubMed ID: 33831792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of health coaching and financial incentives to promote physical activity after total knee replacement.
    Smith KC; Paltiel AD; Yang HY; Collins JE; Katz JN; Losina E
    Osteoarthritis Cartilage; 2018 Nov; 26(11):1495-1505. PubMed ID: 30092263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost utility modeling of early vs late total knee replacement in osteoarthritis patients.
    Mari K; Dégieux P; Mistretta F; Guillemin F; Richette P
    Osteoarthritis Cartilage; 2016 Dec; 24(12):2069-2076. PubMed ID: 27492465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.
    Shah BD; Smith NJ; Feng C; Jeyakumar S; Castaigne JG; Faghmous I; Masouleh BK; Malone DC; Bishop MR
    Adv Ther; 2022 Aug; 39(8):3678-3695. PubMed ID: 35727476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Bariatric Surgery Prior to Total Knee Arthroplasty in the Morbidly Obese: A Computer Model-Based Evaluation.
    McLawhorn AS; Southren D; Wang YC; Marx RG; Dodwell ER
    J Bone Joint Surg Am; 2016 Jan; 98(2):e6. PubMed ID: 26791039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cost-Effectiveness of Platelet-Rich Plasma Injections for Knee Osteoarthritis: A Markov Decision Analysis.
    Rajan PV; Ng MK; Klika A; Kamath AF; Muschler GF; Higuera CA; Piuzzi NS
    J Bone Joint Surg Am; 2020 Sep; 102(18):e104. PubMed ID: 32453118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of primarily surgical versus primarily conservative treatment of acute and subacute radiculopathies due to intervertebral disc herniation from the Swiss perspective.
    Ademi Z; Gloy V; Glinz D; Raatz H; Van Stiphout J; Bucher HC; Schwenkglenks M
    Swiss Med Wkly; 2016; 146():w14382. PubMed ID: 27922167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Total Knee Arthroplasty vs Nonoperative Management in Normal, Overweight, Obese, Severely Obese, Morbidly Obese, and Super-Obese Patients: A Markov Model.
    Ponnusamy KE; Vasarhelyi EM; Somerville L; McCalden RW; Marsh JD
    J Arthroplasty; 2018 Jul; 33(7S):S32-S38. PubMed ID: 29550168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of surgical treatment of medial unicompartmental knee osteoarthritis in younger patients: a computer model-based evaluation.
    Konopka JF; Gomoll AH; Thornhill TS; Katz JN; Losina E
    J Bone Joint Surg Am; 2015 May; 97(10):807-17. PubMed ID: 25995491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
    Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
    Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation.
    Clarke A; Pulikottil-Jacob R; Grove A; Freeman K; Mistry H; Tsertsvadze A; Connock M; Court R; Kandala NB; Costa M; Suri G; Metcalfe D; Crowther M; Morrow S; Johnson S; Sutcliffe P
    Health Technol Assess; 2015 Jan; 19(10):1-668, vii-viii. PubMed ID: 25634033
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.